- $1.10bn
- $5.34bn
- $742.79m
- 62
- 87
- 80
- 90
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 744 | 714 | 727 | 740 | 743 |
Cost of Revenue | |||||
Gross Profit | 479 | 447 | 461 | 463 | 449 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 587 | 569 | 558 | 570 | 607 |
Operating Profit | 156 | 145 | 169 | 170 | 136 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.52 | -12.6 | 5.7 | -24.9 | -370 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.21 | -14.1 | 2.06 | -28.2 | -371 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -36.9 | -24.7 | -20.4 | -36.4 | -260 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -37 | -24.8 | -20.4 | -36.5 | -260 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.044 | 0.011 | -0.093 | -0.153 | -0.905 |
Dividends per Share |